
Novartis Venture Fund
Founded 1996 · Basel, Switzerland
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Need an MVP before applying?
Turn your startup idea into a working web app using AI. No coding required.
Alumni startups
147
Total investments
259
Successful exits
72
About the program
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug delivery systems. In their investments, they look for unmet needs and clinical impact, novel proprietary science, an understanding of mechanism, management and board experience, and capital efficiency in the program. Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress. Their approach involves larger focused investments, with anticipation of total investments up to USD 30 to 50 million per company over its life, but it can be as little as 100,000 USD to get started. They plan to increase their activities to lead or co-lead deals further and remain open to participating in larger syndicates.
Location
Investment offer
Numbers
FAQs about Novartis Venture Fund
What is Novartis Venture Fund?
Novartis Venture Fund is a Venture Capital Firm, Corporate VC. Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Is Novartis Venture Fund an incubator, accelerator, or VC?
Novartis Venture Fund is listed as Venture Capital Firm, Corporate VC. See the profile below for funding stages, offer, and application details.